Monascus rice products

Area of Science:

• Food Science and Technology
• Mycology
• Biochemistry

Background:

• Monascus rice products (MRPs) have a long history of use as food and traditional remedies in Asia.
• MRPs are recognized for producing valuable metabolites like food colorants and cholesterol-lowering agents.
• Key bioactive compounds include monacolin K (a HMG-CoA reductase inhibitor) and the mycotoxin citrinin.

Purpose of the Study:

• To review the applications and bioactive compounds of Monascus rice products.
• To highlight the cholesterol-lowering properties of monacolin K and other MRP constituents.
• To address safety concerns related to citrinin and explore broader health potentials of MRPs.

Main Methods:

• Literature review of studies on Monascus fermentation and its products.
• Analysis of identified bioactive compounds and their pharmacological effects.
• Elucidation of biosynthetic pathways for key metabolites.

Main Results:

• Monascus spp. produce monacolin K, equivalent to lovastatin, for cholesterol reduction.
• Several Monascus species also produce citrinin, a potentially harmful mycotoxin.
• MRPs contain additional compounds (flavonoids, phytosterols) with diverse biological activities.

Conclusions:

• MRPs possess significant potential for cholesterol management and metabolic syndrome treatment.
• The presence of beneficial compounds suggests broader pharmacological applications beyond monacolin K.
• Safety assessments are crucial due to the co-production of monacolin K and citrinin.